Skip to contentSkip to footer
The Quit For Life® Mobile App

Best-in-class products for
the best possible outcomes.

The Quit For Life® Mobile App

Brought to you by the American Cancer Society® and Alere Wellbeing,
the Quit For Life® Program is designed to help you quit smoking and
stay quit for life.

Learn more about Quit For Life

Alere Determine™ HIV-1/2 Ag/Ab Combo

Best-in-class products for
the best possible outcomes.

Alere Determine™ HIV-1/2 Ag/Ab Combo

Introducing the first FDA approved rapid point-of-care test that detects
both HIV-1/2 antibodies and free HIV-1 p24 antigen. It enables health
care providers to diagnose HIV infection earlier allowing individuals to
seek medical care sooner.

Learn more about Alere Determine

Afinion™ HbA1C Test

Best-in-class products for
the best possible outcomes.

Afinion™ HbA1C Test

Used to monitor metabolic control in patients with diabetes.

• 3 minute test time
• Excellent precision (<3% CV)
• No interference from hemobglobin variants

Learn more about the Afinion HbA1c Test

The Quit For Life® Mobile App

Mobile motivation to help you quit smoking.

Learn more

Alere Determine™ HIV-1/2
Ag/Ab Combo

Detecting HIV sooner than antibody 
only tests.

Learn more

Afinion™ HbA1C

Manage diabetes at the point of care.

Learn more

Weekly Coagulation Self-testing among Warfarin Patients Significantly Improves Outcomes

Weekly Coagulation Self-testing among Warfarin Patients
Significantly Improves Outcomes

Results of Study published in the American Journal of Managed Care show highest rate of control ever observed with Warfarin in
real-world setting, surpassing thresholds for cost-effectiveness of newer agents identified in five recent Independent Studies.

Read press release for the full story